Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?

ISSN
1528-0020
0006-4971
Date Issued
2014
Author(s)
Bokelmann, Kristin
Mueller, Thomas
Koepsell, Hermann
DOI
10.1182/blood-2013-11-535864